Associate Research Scientist in Neurology
- Biological Therapy
- Clinical Protocols
- Immune System Diseases
We have used validated methods on the Biomek FX and NX to thaw and immunophenotype (under sterile enclosure) batches of 24 or 48 coded West Nile and Type 1 diabetes samples before and after treatment. Samples were washed and counted using an automated counter (Guava) and the cell suspension adjusted to the appropriate concentration, processed and stained or stimulated and stained in a 96 well format using an automated platform. Data was acquired using 2 LSR Fortessa flow cytometers equipped with high throughput 96 well samplers, cell populations were also sorted using Aria. We use CST beads and specific application settings to minimize the variations that could be introduced by the flow cytometer laser performance on different days. We use automated compensation set on compbeads to standardize the flow data between different batches. To track the reproducibility of the assays and to monitor the acceptability of the %CV between different runs, one cryovial from a bank of frozen PBMC vials generated from single leukopack is processed and run simultaneously on the platform.
Current and future projects include: immune system phenogenetic profiling, ACE autoimmune diseases project, influenza vaccine project, different MS projects in the lab, collaborative projects with companies making new drugs to treat MS.